Luc-André Granier
Vorsitzender bei Averoa SAS
Aktive Positionen von Luc-André Granier
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Société Française d'Etude et de Traitement de la Douleur | Corporate Officer/Principal | - | - |
International League Against Epilepsy | Corporate Officer/Principal | - | - |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - | - |
International Pediatric Nephrology Association | Corporate Officer/Principal | - | - |
Averoa SAS
Averoa SAS Miscellaneous Commercial ServicesCommercial Services Averoa SAS is a French biotechnology company founded in 2021. The private company is based in Grenoble, France and engages in research and development in biotechnology. | Vorsitzender | - | - |
Karriereverlauf von Luc-André Granier
Ehemalige bekannte Positionen von Luc-André Granier
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADVICENNE | Vorstandsvorsitzender | 01.01.2007 | 13.03.2020 |
Vorsitzender | 19.05.2011 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 19.05.2011 | 13.03.2020 | |
Gründer | 01.01.2007 | 13.03.2020 | |
THERANEXUS | Direktor/Vorstandsmitglied | 26.09.2017 | 01.01.2020 |
Vorsitzender | 26.09.2017 | - | |
Independent Dir/Board Member | 26.09.2017 | 01.01.2020 | |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Corporate Officer/Principal | - | - |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Corporate Officer/Principal | - | - |
░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░ ░░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Luc-André Granier
University of Strasbourg | Doctorate Degree |
Statistik
International
Frankreich | 8 |
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 8 |
Chairman | 3 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 5 |
Commercial Services | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ADVICENNE | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
THERANEXUS | Health Technology |
Private Unternehmen | 8 |
---|---|
Société Française d'Etude et de Traitement de la Douleur | |
International Association for the Study of Pain
International Association for the Study of Pain Miscellaneous Commercial ServicesCommercial Services International Association for the Study of Pain operates as a professional forum for science, practice, and education in the field of pain. It brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain. The company was founded in 1973 and is headquartered in Washington, DC. | Commercial Services |
International League Against Epilepsy | |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Commercial Services |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Health Services |
International Pediatric Nephrology Association | |
Averoa SAS
Averoa SAS Miscellaneous Commercial ServicesCommercial Services Averoa SAS is a French biotechnology company founded in 2021. The private company is based in Grenoble, France and engages in research and development in biotechnology. | Commercial Services |
- Börse
- Insiders
- Luc-André Granier
- Erfahrung